Clinical Trials Browser

Interventional × Has results × olaratumab × Clear all

NCT02451943 2025-07-15

ANNOUNCE

Phase 3 Completed

509 enrolled 23 charts

Leiomyosarcoma, Liposarcoma, Sarcoma, Histiocytoma, Malignant Fibrous

NCT03086369 2022-06-28

A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab (LY3012207) in Participants With Metastatic Pancreatic Cancer

Phase 1/2 Completed

184 enrolled 22 charts

Gastrointestinal

Pancreatic Neoplasms

NCT02377752 2021-02-17

A Study of Olaratumab in Japanese Participants With Advanced Cancer

Phase 1 Completed

25 enrolled 19 charts

Neoplasms

NCT03283696 2020-09-10

A Study of Olaratumab (LY3012207), Doxorubicin, and Ifosfamide in Participants With Advanced or Metastatic Soft Tissue Sarcoma

Phase 1 Completed

24 enrolled 21 charts

Sarcoma

NCT02677116 2020-05-20

A Study of Olaratumab Alone and in Combination With Standard Chemotherapies in Children With Cancer

Phase 1 Completed

68 enrolled 26 charts

Neoplasm Metastasis

NCT02326025 2019-11-21

A Study of Olaratumab and Doxorubicin in Participants With Advanced Soft Tissue Sarcoma

Phase 1 Completed

49 enrolled 17 charts

Sarcoma

NCT00913835 2019-09-26

A Study of Liposomal Doxorubicin With or Without Olaratumab (IMC-3G3) in Platinum-Refractory or Resistant Advanced Ovarian Cancer

Phase 2 Completed

125 enrolled 20 charts

Neoplasms, Ovarian Neoplasms

NCT01204710 2019-09-20

A Study of Olaratumab (IMC-3G3) in Prostate Cancer

Phase 2 Completed

123 enrolled 21 charts

Prostatic Neoplasms

NCT02783599 2019-08-12

A Study of Olaratumab (LY3012207) in Participants With Soft Tissue Sarcoma

Phase 1 Completed

51 enrolled 22 charts

Sarcoma

NCT00918203 2019-01-10

A Study of Paclitaxel/Carboplatin With or Without Olaratumab (IMC-3G3) in Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Phase 2 Completed

137 enrolled 23 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00895180 2017-12-27

Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme

Phase 2 Completed

80 enrolled 15 charts

Brain Neoplasms, Glioblastoma, Gliosarcoma

NCT01185964 2017-04-14

A Study of Olaratumab in Soft Tissue Sarcoma

Phase 1/2 Completed

148 enrolled 21 charts

Sarcoma

NCT01316263 2017-03-09

A Study of Olaratumab (IMC-3G3) in Previously Treated Participants With Unresectable and/or Metastatic Gastrointestinal Stromal Tumors

Phase 2 Terminated

21 enrolled 24 charts

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors